Operating
Payments For Operating Costs And Professional Services
Royalty Pharma Payments For Operating Costs And Professional Services decreased by 37.8% to $36.25M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 64.4%, from $101.70M to $36.25M. Over 4 years (FY 2021 to FY 2025), Payments For Operating Costs And Professional Services shows an upward trend with a 11.8% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2018
Last reportedQ1 2026May 6, 2026
How to read this metric
A decrease relative to revenue indicates improved operational efficiency and better margins.
Detailed definition
Represents the cash outflows required for the day-to-day administration, legal, professional services, and general overh...
Peer comparison
Comparable to SG&A cash outflows in any corporate entity.
Metric ID:
operating_payments_for_operating_costs_and_professional__a23282Historical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $39.60M | $53.51M | $49.24M | $48.90M | $44.10M | $48.65M | $81.32M | $86.85M | $47.03M | $54.96M | $54.17M | $60.52M | $48.05M | $55.23M | $72.42M | $101.70M | $94.03M | $34.18M | $58.24M | $36.25M |
| QoQ Change | — | +35.1% | -8.0% | -0.7% | -9.8% | +10.3% | +67.1% | +6.8% | -45.8% | +16.9% | -1.4% | +11.7% | -20.6% | +14.9% | +31.1% | +40.4% | -7.5% | -63.7% | +70.4% | -37.8% |
| YoY Change | — | — | — | — | +11.4% | -9.1% | +65.1% | +77.6% | +6.6% | +13.0% | -33.4% | -30.3% | +2.2% | +0.5% | +33.7% | +68.0% | +95.7% | -38.1% | -19.6% | -64.4% |
Range$34.18M – $101.70M
CAGR-1.8%
Avg YoY Growth+11.2%
Median YoY Growth+4.4%
Payments For Operating Costs And Professional Services at Other Companies
Frequently Asked Questions
- What is Royalty Pharma's payments for operating costs and professional services?
- Royalty Pharma (RPRX) reported payments for operating costs and professional services of $36.25M in Q1 2026.
- How has Royalty Pharma's payments for operating costs and professional services changed year-over-year?
- Royalty Pharma's payments for operating costs and professional services decreased by 64.4% year-over-year, from $101.70M to $36.25M.
- What is the long-term trend for Royalty Pharma's payments for operating costs and professional services?
- Over 4 years (2021 to 2025), Royalty Pharma's payments for operating costs and professional services has grown at a 11.8% compound annual growth rate (CAGR), from $184.51M to $288.14M.
- What does payments for operating costs and professional services mean?
- Cash spent on general administrative and professional service expenses.